Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

Overview of attention for article published in The Lancet, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 39 news outlets
blogs: 8 blogs
twitter: 436 X users

facebook: 1 Facebook page
video: 1 YouTube creator

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 136 Mendeley

Summary News Blogs X Facebook YouTube Dimensions citations

So far, Altmetric has seen 1 public wall post.

Centre for Evidence-based Medicine, 30 Jan 2022

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01210-1/fulltext?dgcid=raven_jbs_etoc_email

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.